CSS LLC/IL - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$7,112,000
-2.4%
7,007,0000.0%0.26%
-0.8%
Q4 2021$7,290,000
-0.3%
7,007,0000.0%0.26%
-16.7%
Q3 2021$7,311,000
-3.1%
7,007,0000.0%0.31%
-0.3%
Q2 2021$7,544,000
-6.4%
7,007,0000.0%0.31%
-5.7%
Q1 2021$8,057,000
-10.6%
7,007,0000.0%0.33%
-4.1%
Q4 2020$9,010,000
+13.4%
7,007,0000.0%0.34%
-8.2%
Q3 2020$7,947,000
+20.9%
7,007,000
+23.9%
0.38%
+1.1%
Q2 2020$6,574,000
+240.1%
5,657,000
+223.3%
0.37%
+235.1%
Q2 2019$1,933,000
-6.7%
1,750,000
-12.5%
0.11%
-10.5%
Q1 2019$2,072,000
-30.8%
2,000,000
-33.3%
0.12%
-38.3%
Q4 2018$2,993,000
+505.9%
3,000,000
+500.0%
0.20%
+773.9%
Q2 2018$494,000500,0000.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 31,204,000$31,610,0000.98%
Opti Capital Management, LP 8,000,000$8,206,0000.66%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 14,527,000$15,076,0000.34%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,519,000$15,848,0000.31%
CSS LLC/IL 7,007,000$7,112,0000.26%
WOLVERINE ASSET MANAGEMENT LLC 17,479,000$17,762,0000.17%
LMR Partners LLP 9,500,000$9,933,0000.12%
PALISADE CAPITAL MANAGEMENT, LP 4,672,000$4,858,0000.11%
Verition Fund Management LLC 8,091,000$8,233,0000.10%
Aequim Alternative Investments LP 2,000,000$2,035,0000.05%
View complete list of PTC THERAPEUTICS INC shareholders